-
Targeting RAS mutants in malignancies: successes, failures, and reasons for hope
Author: Yang, Hang; Zhou, Xinyi; Fu, Dongliang; Le, Chenqin; Wang, Jiafeng; Zhou, Quan; Liu, Xiangrui; Yuan, Ying; Ding, Kefeng; Xiao, Qian
Journal: CANCER COMMUNICATIONS. 2023; Vol. 43, Issue 1, pp. 42-74. DOI: 10.1002/cac2.12377
-
circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer
Author: Yang, Yufei; Luo, Dakui; Shao, Yang; Shan, Zezhi; Liu, Qi; Weng, Junyong; He, Weijing; Zhang, Ruoxin; Li, Qingguo; Wang, Ziliang; Li, Xinxiang
Journal: CANCER COMMUNICATIONS. 2023; Vol. 43, Issue 1, pp. 100-122. DOI: 10.1002/cac2.12380
-
Elevated neutrophil extracellular traps by HBV-mediated S100A9-TLR4/RAGE-ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma
Author: Zhan, Xi; Wu, Rui; Kong, Xue-Hua; You, Yan; He, Kun; Sun, Xiao-Yu; Huang, Yong; Chen, Wei-Xian; Duan, Liang
Journal: CANCER COMMUNICATIONS. 2023; Vol. 43, Issue 2, pp. 225-245. DOI: 10.1002/cac2.12388
-
Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21-mediated ubiquitination/degradation of STAT1 in a GTP binding-dependent modality
Author: Zhang, Lu; Li, Qingya; Yang, Jing; Xu, Penghui; Xuan, Zhe; Xu, Jianghao; Xu, Zekuan
Journal: CANCER COMMUNICATIONS. 2023; Vol. 43, Issue 1, pp. 123-149. DOI: 10.1002/cac2.12386
-
Resistance to antibody-drug conjugates in breast cancer: mechanisms and solutions
Author: Chen, Yu-Fei; Xu, Ying-ying; Shao, Zhi-Ming; Yu, Ke-Da
Journal: CANCER COMMUNICATIONS. 2023; Vol. 43, Issue 3, pp. 297-337. DOI: 10.1002/cac2.12387
-
Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration?
Author: Feng, Ruimei; Su, Qingling; Huang, Xiaoyin; Basnet, Til; Xu, Xin; Ye, Weimin
Journal: CANCER COMMUNICATIONS. 2023; Vol. 43, Issue 1, pp. 75-86. DOI: 10.1002/cac2.12393
-
Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives
Author: Fang, Zengli; Meng, Qingcai; Xu, Jin; Wang, Wei; Zhang, Bo; Liu, Jiang; Liang, Chen; Hua, Jie; Zhao, Yingjun; Yu, Xianjun; Shi, Si
Journal: CANCER COMMUNICATIONS. 2023; Vol. 43, Issue 1, pp. 3-41. DOI: 10.1002/cac2.12392
-
Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors
Author: Liu, Fei; Wang, Zixian; Li, Xiaofan; Zhang, Zhen; Yang, Yue; Chen, Junquan; Chen, Dinghua; Wu, Lingling; Liu, Xiangyu; Han, Sujun; Wang, Fangming; Wahafu, Wasilijiang; Gao, Yibo; Ren, Shancheng; Xing, Nianzeng; Cai, Guangyan; Chen, Xiangmei
Journal: CANCER COMMUNICATIONS. 2023; Vol. 43, Issue 2, pp. 214-224. DOI: 10.1002/cac2.12396
